HedgePath Pharmaceuticals, Inc. 4
4 · HedgePath Pharmaceuticals, Inc. · Filed Aug 18, 2015
Insider Transaction Report
Form 4
Cross Stefan
Director
Transactions
- Award
Restricted Stock Units
2015-08-14+300,000→ 300,000 total→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- [F2]The RSUs were issued to the reporting person on August 14, 2015, pursuant to a grant under the issuer's 2014 Equity Incentive Plan. The RSUs will vest in the first open window after the earlier to occur of (i) September 5, 2017 and (ii) approval by the United States Food and Drug Administration of any of the issuer's products that utilize its patented formulation of the drug itraconazole, known as SUBATM-Itraconazole.